← Back to Search

Behavioral Intervention

Brief-SfSL (B-TAU) for Suicide

N/A
Waitlist Available
Led By Sakina Rizvi, PhD, MACP
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Suicidal ideation in the past week
* Access to a computer or phone with a camera
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 3 months post-intervention
Awards & highlights

Summary

The goal of this project is to assess the efficacy of Brief-Skills for Safer Living (Brief-SfSL) in a randomized control trial. The investigators will be testing 150 participants Canada-wide, half of which will be randomized to receive Brief-SfSL (B-TAU) and the other half will be randomized to receive Brief-SfSL after a 3 month waitlist (WL-TAU). The main questions this study seeks to answer are: * Is B-TAU more efficacious than WL-TAU for reducing suicidal thoughts at 3 months? * Is B-TAU more efficacious than WL-TAU at 3 months for reducing depression severity, anxiety, as well as improving quality of life? * Are adverse events equivalent between B-TAU and WL-TAU at 3 months?

Who is the study for?
This trial is for individuals across Canada dealing with suicidal thoughts or behaviors. Participants will be selected to either receive the Brief-Skills for Safer Living (Brief-SfSL) immediately or after a 3-month waitlist. The study aims to include a diverse group of 150 participants.
What is being tested?
The effectiveness of Brief-SfSL, a suicide prevention intervention, is being tested. Participants are randomly assigned to two groups: one receives the intervention right away (B-TAU), and the other after a delay (WL-TAU). The study compares outcomes in suicidal thoughts, depression, anxiety, and quality of life at 3 months.
What are the potential side effects?
Since this trial involves psychological interventions rather than medication, traditional side effects are not expected. However, discussing sensitive topics like suicide may cause emotional discomfort or distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 3 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in suicidal ideation using Beck Scale for Suicide Ideation
Secondary study objectives
Change in anxiety symptoms using the Generalized Anxiety Disorder 7-item scale (GAD-7)
Change in depression symptoms using the Quick Inventory of Depressive Symptoms 16-item scale (QIDS).
Change in quality of life using the Quality of Life Scale (QoLS)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Brief-SfSL (B-TAU)Experimental Treatment1 Intervention
Participants will receive the Brief-SfSL treatment within 1 week of their screening.
Group II: Wait List (WL-TAU)Active Control1 Intervention
Participants will be put on a wait list and receive the Brief-SfSL treatment 3 months after their screening.

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
550 Previous Clinical Trials
451,074 Total Patients Enrolled
6 Trials studying Suicide
477 Patients Enrolled for Suicide
Sakina Rizvi, PhD, MACPPrincipal InvestigatorUnity Health Toronto
~100 spots leftby Oct 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top